[144] TD SYNNEX CORP SEC Filing

Rhea-AI Filing Summary

TD SYNNEX (SNX) filed a Form 144 notice for a proposed sale of up to 76,848 common shares on the NYSE through Goldman Sachs & Co. LLC, with an approximate sale date of 10/16/2025. The filing lists an aggregate market value of $11,912,208.48 for the shares.

The seller acquired 20,000 shares as RSU compensation on 06/30/2020 from the issuer, and 56,848 shares via stock options granted on 10/05/2021, indicated as a cashless exercise/same-day sale. Shares outstanding were 81,437,855; this is a baseline figure, not the amount being offered.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	76848	11912208.48	81437855	10/16/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/30/2020	Acquired as compensation -- Restricted Stock Units	Issuer			20000	06/30/2020	Compensation
Common	10/05/2021	Acquired as compensation -- Stock Options	Issuer			56848	10/05/2021	Compensation -- Cashless exercise / same-day sale

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did TD SYNNEX (SNX) disclose in this Form 144?

A proposed sale of up to 76,848 common shares with an aggregate market value of $11,912,208.48.

When is the proposed sale for SNX shares expected?

The filing lists an approximate date of sale of 10/16/2025.

Which broker is handling the proposed SNX share sale?

The filing names Goldman Sachs & Co. LLC as broker.

On which exchange are the SNX shares to be sold?

The shares are listed for sale on the NYSE.

How were the SNX shares to be sold originally acquired?

By RSUs (20,000 shares on 06/30/2020) and stock options (56,848 shares on 10/05/2021), including a cashless exercise/same-day sale.

How many SNX shares are outstanding?

The filing lists 81,437,855 shares outstanding.